Back to top Open menu arrow
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

This article is available to members only. Please enjoy the abstract for free. Subscribe for instant access to the full article.

This content is restricted to subscribers

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

  1. Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas
  2. Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas
  3. Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas
  4. Peter O’Donnell Jr School of Public Health, University of Texas Southwestern Medical Center, Dallas, Texas
  5. Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas
  6. Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas
  7. Division of Psychology, University of Texas Southwestern Medical Center, Dallas, Texas
  8. Department of Psychiatry, Children’s Health, Children’s Medical Center, Dallas, Texas
  9. Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas
  10. Department of Psychiatry, Children’s Health, Children’s Medical Center, Dallas, Texas
  11. Corresponding author: Graham J. Emslie, MD, 1341 W Mockingbird Lane Suite 1200 E, Dallas, TX 75247 ([email protected]).
  1. World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. WHO website. https://apps.who.int/iris/handle/10665/254610. 2017.
  2. Bitsko RH, Claussen AH, Lichstein J, et al. Mental health surveillance among children - United States, 2013–2019. MMWR suppl. 2022;71(2):1–42. PubMed CrossRef
  3. Mojtabai R, Olfson M. National trends in mental health care for US adolescents. JAMA Psychiatry. 2020;77(7):703–714. PubMed CrossRef
  4. Maalouf FT, Brent DA. Pharmacotherapy and psychotherapy of pediatric depression. Expert Opin Pharmacother. 2010;11(13):2129–2140. PubMed CrossRef
  5. Yu ZJ, Kratochvil CJ, Weller RA, et al. From TADS and SOFTADS to TORDIA and beyond: what’s new in the treatment of adolescent depression? Curr Psychiatry Rep. 2010;12(2):88–95. PubMed CrossRef
  6. Weersing VR, Jeffreys M, Do MT, et al. Evidence base update of psychosocial treatments for child and adolescent depression. J Clin Child Adolesc Psychol. 2017;46(1):11–43. PubMed CrossRef
  7. Bear HA, Edbrooke-Childs J, Norton S, et al. Systematic review and meta-analysis: outcomes of routine specialist mental health care for young people with depression and/or anxiety. J Am Acad Child Adolesc Psychiatry. 2020;59(7):810–841. PubMed CrossRef
  8. Weisz JR, Kuppens S, Ng MY, et al. What five decades of research tells us about the effects of youth psychological therapy: A multilevel meta-analysis and implications for science and practice. Am Psychol. 2017;72(2):79–117. PubMed CrossRef
  9. Emslie GJ, Mayes T, Porta G, et al. Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes. Am J Psychiatry. 2010;167(7):782–791. PubMed CrossRef
  10. Kennard B, Silva S, Vitiello B, et al; TADS Team. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45(12):1404–1411. PubMed CrossRef
  11. Curry J, Silva S, Rohde P, et al. Recovery and recurrence following treatment for adolescent major depression. Arch Gen Psychiatry. 2011;68(3):263–269. PubMed CrossRef
  12. Breslau J, Gilman SE, Stein BD, et al. Sex differences in recent first-onset depression in an epidemiological sample of adolescents. Transl Psychiatry. 2017;7(5):e1139. PubMed CrossRef
  13. Hankin BL. Development of sex differences in depressive and co-occurring anxious symptoms during adolescence: descriptive trajectories and potential explanations in a multiwave prospective study. J Clin Child Adolesc Psychol. 2009;38(4):460–472. PubMed CrossRef
  14. Gaynes BN, Warden D, Trivedi MH, et al. What did STAR*D teach us? results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv. 2009;60(11):1439–1445. PubMed CrossRef
  15. Serretti A, Gibiino S, Drago A. Specificity profile of paroxetine in major depressive disorder: meta-regression of double-blind, randomized clinical trials. J Affect Disord. 2011;132(1-2):14–25. PubMed CrossRef
  16. Cuijpers P, Weitz E, Twisk J, et al. Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an “individual patient data” meta-analysis. Depress Anxiety. 2014;31(11):941–951. PubMed CrossRef
  17. Kornstein SG, Pedersen RD, Holland PJ, et al. Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the PREVENT study. J Clin Psychiatry. 2014;75(1):62–68. PubMed CrossRef
  18. Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008;165(3):342–351. PubMed CrossRef
  19. Melton TH, Croarkin PE, Strawn JR, et al. Comorbid anxiety and depressive symptoms in children and adolescents: a systematic review and analysis. J Psychiatr Pract. 2016;22(2):84–98. PubMed CrossRef
  20. Ghandour RM, Sherman LJ, Vladutiu CJ, et al. Prevalence and treatment of depression, anxiety, and conduct problems in US children. J Pediatr. 2019;206:256–267.e3. PubMed CrossRef
  21. Trombello JM, Pizzagalli DA, Weissman MM, et al. Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study. J Psychiatr Res. 2018;102:207–215. PubMed CrossRef
  22. Braund TA, Tillman G, Palmer DM, et al. Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report. Transl Psychiatry. 2021;11(1):417. PubMed CrossRef
  23. Fabbri C, Marsano A, Balestri M, et al. Clinical features and drug induced side effects in early versus late antidepressant responders. J Psychiatr Res. 2013;47(10):1309–1318. PubMed CrossRef
  24. Trivedi MH, Wisniewski SR, Morris DW, et al. Concise Associated Symptoms Tracking scale: a brief self-report and clinician rating of symptoms associated with suicidality. J Clin Psychiatry. 2011;72(6):765–774. PubMed CrossRef
  25. Jha MK, Minhajuddin A, South C, et al. Worsening anxiety, irritability, insomnia, or panic predicts poorer antidepressant treatment outcomes: clinical utility and validation of the Concise Associated Symptom Tracking (CAST) Scale. Int J Neuropsychopharmacol. 2018;21(4):325–332. PubMed CrossRef
  26. McAllister-Williams RH, Arango C, Blier P, et al. The identification, assessment and management of difficult-to-treat depression: An international consensus statement. J Affect Disord. 2020;267:264–282. PubMed CrossRef
  27. Zimmerman M, Walsh E, Friedman M, et al. Identifying remission from depression on 3 self-report scales. J Clin Psychiatry. 2017;78(2):177–183. PubMed CrossRef
  28. Trivedi MH. Tools and strategies for ongoing assessment of depression: a measurement-based approach to remission. J Clin Psychiatry. 2009;70(suppl 6):26–31. PubMed CrossRef
  29. Hughes CW, Emslie GJ, Crismon ML, et al; Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. Texas Children’s Medication Algorithm Project: update from Texas Consensus Conference Panel on medication treatment of childhood major depressive disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(6):667–686. PubMed CrossRef
  30. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282(18):1737–1744. PubMed CrossRef
  31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition, Text Revision. American Psychiatric Association.
  32. Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. PubMed CrossRef
  33. Trivedi MH, Wisniewski SR, Morris DW, et al. Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk. J Clin Psychiatry. 2011;72(6):757–764. PubMed CrossRef
  34. Mayes TL, Killian M, Rush AJ, et al. Predicting future suicidal events in adolescents using the Concise Health Risk Tracking Self-Report (CHRT-SR). J Psychiatr Res. 2020;126:19–25. PubMed CrossRef
  35. Jeffrey J, Klomhaus A, Aralis H, et al. Factors associated with response and remission from depression at 6-months of treatment in a retrospective cohort treated within an integrated care program. BMC Health Serv Res. 2021;21(1):703. PubMed CrossRef
  36. Trombello JM, Killian MO, Liao A, et al. Psychometrics of the Self-Report Concise Associated Symptoms Tracking Scale (CAST-SR): results from the STRIDE (CTN-0037) study. J Clin Psychiatry. 2018;79(2):41–47. PubMed CrossRef
  37. Emslie GJ, Wagner KD, Kutcher S, et al. Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2006;45(6):709–719. PubMed CrossRef
  38. Atkinson SD, Prakash A, Zhang Q, et al. A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder. J Child Adolesc Psychopharmacol. 2014;24(4):180–189. PubMed CrossRef
  39. Gaspersz R, Lamers F, Kent JM, et al. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment. J Psychiatr Res. 2017;84:41–48. PubMed CrossRef
  40. Wilkinson P, Dubicka B, Kelvin R, et al. Treated depression in adolescents: predictors of outcome at 28 weeks. Br J Psychiatry. 2009;194(4):334–341. PubMed CrossRef
  41. Derdikman-Eiron R, Indredavik MS, Bratberg GH, et al. Gender differences in subjective well-being, self-esteem and psychosocial functioning in adolescents with symptoms of anxiety and depression: findings from the Nord-Trøndelag Health Study. Scand J Psychol. 2011;52(3):261–267. PubMed CrossRef
  42. Ma D, Zhang Z, Zhang X, et al. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis. Curr Med Res Opin. 2014;30(6):971–995. PubMed CrossRef
  43. Forbes EE, Stepp SD, Dahl RE, et al. Real-world affect and social context as predictors of treatment response in child and adolescent depression and anxiety: an ecological momentary assessment study. J Child Adolesc Psychopharmacol. 2012;22(1):37–47. PubMed CrossRef
  44. Scardera S, Perret LC, Ouellet-Morin I, et al. Association of social support during adolescence with depression, anxiety, and suicidal ideation in young adults. JAMA Netw Open. 2020;3(12):e2027491. PubMed CrossRef

Save Save

Share Share

Cite Cite

Read the Current Issue

Vol 85, 2024 3

Can Our Collective Experiences As Clinicians Improve Mental Health Care?

SSRI Discontinuation and AUD Relapse

Reproductive Pharmacovigilance and Best Practices

Olanzapine and Mirtazapine for Cancer-Related Anorexia

Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia

Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
View current Issue

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe